Pediatric Neurosurgery
Complication Review
Chiari I Malformations and Hydromyelia – ComplicationsMenezes A.H.Division of Neurosurgery, University of Iowa Hospitals, Iowa City, Iowa, USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: March 05, 2008
Issue release date: 1992
Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 0
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Abstract
The Chiari I malformation is associated with a hydromyelic cavity in 55–75% of patients. In the author’s series (1977–1991), hydromyelia occurred in 111 of 131 patients (85%). There were 35 children. Posterior fossa decompression with duraplasty and fourth ventricle to subarachnoid shunt was made in all patients with Chiari I malformation with hydromyelia. The obex connection to the cervical cord central canal was closed with muscle, if widely patent. Eighty-five percent showed sustained objective improvement. The precautions taken to avoid complications and a literature review are tabulated for easy reference.
© 1992 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: March 05, 2008
Issue release date: 1992
Number of Print Pages: 9
Number of Figures: 0
Number of Tables: 0
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission